USA flag logo/image

An Official Website of the United States Government

THE APPLICATION'S LONG-TERM OBJECTIVE IS TO DEVELOP A MORE EFFECTIVE, SAFE,…

Award Information

Agency:
Department of Health and Human Services
Branch:
N/A
Award ID:
3135
Program Year/Program:
1985 / SBIR
Agency Tracking Number:
3135
Solicitation Year:
N/A
Solicitation Topic Code:
N/A
Solicitation Number:
N/A
Small Business Information
LOHOCLA RESEARCH CORPORATION
12635 E. Montview Blvd. AURORA, CO 80045-7337
View profile »
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
 
Phase 1
Fiscal Year: 1985
Title: THE APPLICATION'S LONG-TERM OBJECTIVE IS TO DEVELOP A MORE EFFECTIVE, SAFE, RELATIVELY LONG-TERM BARRIER CONTRACEPTIVE DEVICE.
Agency: HHS
Contract: N/A
Award Amount: $45,800.00
 

Abstract:

THE APPLICATION'S LONG-TERM OBJECTIVE IS TO DEVELOP A MORE EFFECTIVE, SAFE, RELATIVELY LONG-TERM BARRIER CONTRACEPTIVE DEVICE. DEVELOPMENT OF THE PROPOSED DEVICE WILL HAVE SIGNIFICANT IMPACT ON EFFECTIVE CONTROL OF OVERPOPULATION AND REDUCTION OF ABORTIONS SECONDARY TO UNWANTED PREGNANCIES. THE APPLICANTS' SPECIFIC AIMS ARE 1. TO DEVELOP A POLYMER MATRIX SYSTEM IN WHICH AN IMPROVED CONTRACEPTIVE AGENT IS INCORPORATED; AND 2. TO DETERMINE PHYSICAL AND CHEMICAL PROPERTIES OF THE DEVICE WHICH WILL ALLOW FOR THE LONG-TERM RELEASE OF SUFFICIENT AGENT THAT WILL RENDER THE DEVICE CONTRACEPTIVELY EFFICACIOUS. THESE AIMS WILL BE MET BY INCORPORATING AN ACTIVE AGENT (L-21985) WITH KNOWN CONTRACEPTIVE EFFICACY AND LOW TOXICITY INTO A COPOLYMER MATRIX. RELEASE OF L-21985 FROM THE MATRIX WILL BE QUANTIFIED BY ENZYMIC ASSAY. RELEASE RATES WILL BE OPTIMIZED BY VARYING THE MONOMER RATIO OF THE COPOLYMER MATRIX, THE PARTICLE SIZE OF THE ACTIVE AGENT INCORPORATED INTO THE MATRIX, AND THE PERCENT LOADING OF THE ACTIVE AGENT INTO THE MATRIX. OPTIMIZATION OF THESE VARIABLES TO PRODUCE A COMPOSITE DEVICE WHICH RELEASES CONTRACEPTIVE LEVELS OF L-21985 FOR PERIODS UP TO 14 DAYS WILL REPRESENT THE SUCCESSFUL COMPLETION OF PHASE I. THIS END POINT IS PREREQUISITE TO PHASE II OBJECTIVES OF 1. INCORPORATING THE POLYMER MATRIX INTO AN EXISTING BARRIER-TYPE CONTRACEPTIVE DEVICE (E.G., VAGINAL RING, CERVICAL CAP); AND 2. EVALUATING THE COMPOSITE DEVICE IN PHASE I CLINICAL TRIALS. THE PROPOSED PROJECT WILL LEAD TO THE DEVELOPMENT OF A SAFE, HIGHLY EFFECTIVE, RELATIVELY LONG-LASTING, EASY-TO-USE CONTRACEPTIVE DEVICE. THESE ATTRIBUTES ARE CLEARLY COMPATIBLE WITH A PRODUCT WITH HIGH MARKET POTENTIAL.

Principal Investigator:

Robert a. anderson jr.
PRINCIPAL INVESTIGATOR
3126630797

Business Contact:

Small Business Information at Submission:

Lohocla Research Corpon
P.o. Box 8405 Chicago, IL 60680

EIN/Tax ID:
DUNS: N/A
Number of Employees: N/A
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No